Drug Type CAR-NK |
Synonyms- |
Target |
Mechanism CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors), NKG2A antagonists(killer cell lectin like receptor C1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adult Acute Myeloblastic Leukemia | Preclinical | US | 09 Dec 2022 | |
Adult Acute Myeloblastic Leukemia | Preclinical | DE | 09 Dec 2022 | |
Acute Myeloid Leukemia | Preclinical | US | 13 Apr 2022 | |
Acute Myeloid Leukemia | Preclinical | DE | 13 Apr 2022 |